Biometrics IP Portfolio – 5 U.S. Patents and 1 Application

TransactionsIP is representing Global E-Dentity in selling their Biometrics IP Portfolio (3 Patents – Biometric authentication of individuals utilizing characteristics of bone and blood vessel structures); and an Application for Biometrics for Augmented Reality or Virtual Reality.

In addition, the first 2 covid detection patents issued: US 10,880,303 & US 16/953,087 (NOA)-  REAL-TIME COVID-19 OUTBREAK IDENTIFICATION WITH NON-INVASIVE, INTERNAL IMAGING FOR DUAL BIOMETRIC AUTHENTICATION AND BIOMETRIC HEALTH MONITORING.

Recently, 2 new NOAs have been added as well. US 16/953,087 – “Real-time covid-19 outbreak identification with non-invasive, internal imaging for dual biometric authentication and biometric health monitoring” and US 17/525,844 – BIOMETRIC AUTHENTICATION FOR AN AUGMENTED REALITY OR A VIRTUAL REALITY DEVICE – CIP

In simple terms, this is akin to an electronic-nose biometrics device like a sniffer that detects the Covid virus in one’s hand or body part including on the breath, conceptually like an explosives detection dog does, by immediately recognizing chemical signatures.

“Our company has developed a patented process to detect COVID (and potentially other such viruses) through an electronic-nose biometrics device that could be deployed at airports and other ports of entry, or in schools or places of employment, providing results in seconds.” Dr. Adams –  CEO and Founder of Global E-Dentity.

To receive a Brokerage Marketing Package, please contact Rich Ehrlickman; [email protected], 845-558-8300.

Share:

Send Us A Message